Registry of Lobbyists
Version 11 of 69 (2007-07-20 to 2008-01-09) was submitted prior to the Lobbying Act coming into force on July 2, 2008. Due to different information requirements at that time, the registration is presented in the following format.
| Corporation: |
GlaxoSmithKline
7333 Mississauga Road Mississauga, ON L5N 6L4 Canada |
| Telephone number: | 905-819-3000 |
| Fax number: | 905-819-3099 |
| Responsible officer name and position during the period of this registration: | Paul Lucas, President and CEO |
| Description of activities: | GLAXOSMITHKLINE IS ONE OF CANADA'S LARGEST RESEARCH-BASED PHARMACEUTICAL COMPANIES. GLAXOSMITHKLILNE OPERATES FOUR MAIN FACILITIES IN CANADA, INCLUDING ITS HEAD OFFICE AND MANUFACTURING OPERATIONS IN MISSISSAUGA, AND ITS BUREAU D'AFFAURES DU QUEBEC IN MONTREAL. IN TOTAL GLAXOSMITHKLINE EMPLOYS APPROXIMATELY 1,800 PEOPLE ACROSS THE COUNTRY. GSK IS A LEADER IN MANY IMPORTANT THERAPEUTIC AREAS, INCLUDING RESPIRATORY, CENTRAL NERVOUS SYSTEM, ANTI-INFECTIVES AND GASTRO INTESTINAL/METABOLIC. GLAXOSMITHKLINE INVESTS MORE THAN $100 MILLION IN RESEARCH & DEVELOPMENT IN CANADA EACH YEAR. GLAXOSMITHKLINE'S $120 MILLION MANUFACTURING OPERATIONS PRODUCE MORE THAN 100 MEDICINES AND 20 MILLION UNITS ANNUALLY. |
| The client is a subsidiary of the following parent companies: |
GlaxoSmithKline plc
980 Great West Road Brentford, Middlesex TW89GS United Kingdom |
| Coalition | The corporation is not a member of a coalition. |
| Subsidiary: | The corporation does not have any subsidiaries that could be affected by the outcome of the undertaking. |
| Other direct interests | The corporation's activities are not controlled or directed by another individual, organization or corporation with a direct interest in the outcome of this undertaking. |
| Was the corporation funded in whole or in part by any domestic or foreign government institution in the last completed financial year? | No |
| Name: | Bryan Jones |
| Position title: | Manager |
| Public offices held: | Yes |
| Name: | Jacqueline LaRocque |
| Position title: | Manager, Public Policy |
| Public offices held: | Yes |
| Name: | Geoff Mitchinson |
| Position title: | Vice President, Public Affairs and Reimbursement |
| Public offices held: | No |
| Name: | Doug Nanton |
| Position title: | Manager |
| Public offices held: | No |
| Name: | Grant Perry |
| Position title: | Director, Federal Affairs and Reimbursement |
| Public offices held: | Yes |
| Federal departments or organizations which have been or will be communicated with during the course of the undertaking: | Affaires autochtones et Développement du Nord Canada, Affaires étrangères et Commerce international Canada (MAECIC), Agence canadienne de développement international (ACDI), Agence de promotion économique du Canada atlantique (APECA), Bureau du Conseil privé (BCP), Bureau fédéral de développement régional (Québec) (BFDR[Q]), Cabinet du Premier ministre (CPM), Conseil d'examen du prix des médicaments brevetés (CEPMB), Conseil de recherches en sciences naturelles et en génie (CRSNG), Conseil national de recherches (CNRC), Députés de la Chambre des communes, Environnement Canada, Finances Canada (FIN), Industrie Canada, Partenariat technologie Canada (PTC), Revenu Canada (RC), Santé Canada (SC), Secrétariat du Conseil du Trésor du Canada (SCT), Travaux publics et Services gouvernementaux Canada, Tribunal canadien du commerce extérieur (TCCE), Tribunal de la concurrence (TC) | ||||||||
|
Communication techniques that have been used or are expected to be used in the course of the undertaking:
|
Appel au grand public, Appels téléphoniques, Communications informelles, Communications écrites, en format papier ou électronique, Présentations, Réunions | ||||||||
| Subject Matter: Areas of Concern: | Commerce intérieur, Commerce international, Développement régional, Emploi et formation, Impôts et finances, Industrie, Institutions financières, Marchés publics, Propriété intellectuelle, Questions constitutionnelles, Questions touchant les consommateurs, Relations internationales, Santé, Sciences et technologies, Travail | ||||||||
| Subject Matter: Retrospective: | ANY LEGISLATIVE PROPOSALS, POLICIES OR PAPERS, BILLS OR RESOLUTIONS, OR REGULATIONS THAT WOULD IMPACT THE BRAND NAME PHARMACEUTICAL INDUSTRY OR THE REVIEW OF ANY DRUG PATENT LEGISLATION; PHARMACARE OR HOME CARE PROGRAMS; NATIONAL PHARMACEUTICALS STRATEGY, DRUG APPROVALS POLICIES AND PROCESSES AS WELL AS GOVERNMENT PURCHASES OF VACCINES. | ||||||||
| Subject Matter: Prospective: | ANY LEGISLATIVE PROPOSALS, POLICIES OR PAPERS, BILLS OR RESOLUTIONS, OR REGULATIONS THAT WOULD IMPACT THE BRAND NAME PHARMACEUTICAL INDUSTRY OR THE REVIEW OF ANY DRUG PATENT LEGISLATION; PHARMACARE OR HOME CARE PROGRAMS; DRUG APPROVALS POLICIES AND PROCESSES AS WELL AS GOVERNMENT PURCHASES OF VACCINES. | ||||||||
Details Regarding the Identified Subject Matter
|
|||||||||